Nxera Pharma's Partner, Neurocrine Biosciences, Initiates Phase 1 Study for Promising Investigational Compound, NBI-1117567

Nxera Pharma  notes that its partner Neurocrine Biosciences  a leading neuroscience-focused biopharmaceutical company, announced that it has init...

May 09, 2024 | Thursday | News
MSD Expands Access to High-Quality Maternal Care for More Than 30 Million Women Worldwide Through Merck for Mothers

  Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Merck for Mothers, the company’s global materna...

May 09, 2024 | Thursday | News
Bio-Rad's CEO, Norman Schwartz, Finds Hope in Adversity: "Our Vision Remains Strong Despite Market Challenges"

  First-quarter 2024 total net sales were $610.8 million, a decrease of 9.8 percent compared to $676.8 million reported for the first quarter of 2023...

May 08, 2024 | Wednesday | Company results
Walgreens and Boehringer Ingelheim Forge Strategic Partnership to Democratize Clinical Trials

Walgreens and Boehringer Ingelheim announced a strategic collaboration aimed at optimizing recruitment and making clinical trials more accessible, inclusiv...

May 03, 2024 | Friday | News
BrioHealth Solutions Granted FDA Approval to Commence Landmark Trial for Novel Heart Failure Treatment

BrioHealth Solutions, Inc., a medical technology company focused on developing innovative advanced heart failure solutions, announced it has received FDA I...

May 02, 2024 | Thursday | News
MGI Tech Launches Customer Experience Center in Brazil to Drive Genomics Advancement in Latin America

Contributing to the advancement of genomics in Latin America, MGI Tech Co. Ltd. (MGI), a company committed to building core tools and t...

April 29, 2024 | Monday | News
INTREPID Alliance Identifies Most Promising Antiviral Compounds in Global Pipeline Aligned with Pandemic Preparedness Recommendations

Detailed scientific analysis of antiviral pipeline identifies most promising clinical compounds aligned with 100 Days Mission global preparedness recommend...

April 29, 2024 | Monday | News
Celltrion USA Secures ZYMFENTRA Access Agreement with Express Scripts

Celltrion USA announced that it has signed an agreement with Express Scripts, one of the nation's leading pharmacy benefit managers (PBMs) negotiating on b...

April 29, 2024 | Monday | News
New Study Shows Bausch + Lomb's Blink™ NutriTears® Offers Significant Relief for Dry Eye Symptoms

Bausch + Lomb Corporation, a leading global eye health company dedicated to helping people see better to live better, today announced Frontiers in Ophthalm...

April 26, 2024 | Friday | News
Hyundai Bioscience Announces Clinical Development Plan for Oral Niclosamide Metabolic Anticancer Drug Targeting p53 Gene Mutations

Hyundai Bioscience announced its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer patients with intractable cance...

April 25, 2024 | Thursday | News
Gain Therapeutics Reports Positive Results from Phase 1 Study of GT-02287, Showcasing Promising Safety and Tolerability Profile

Gain Therapeutics, a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapi...

April 25, 2024 | Thursday | News
Ipsen Strikes Option Agreement with Skyhawk for Exclusive Global Rights to Novel Neurological Disease Candidates

Ipsen enters into an option agreement to receive exclusive global rights to two candidates pursued under the collaboration Following development candida...

April 22, 2024 | Monday | News
SK pharmteco Partners with Ferring Pharmaceuticals to Scale Up Production of ADSTILADRIN® Gene Therapy

Biopharmaceutical contract manufacturer SK pharmteco commits to production, testing, and release of Ferring’s U.S. approved ADSTILADRIN® ...

April 18, 2024 | Thursday | News
GE HealthCare Launches Voluson Signature 20 and 18 Ultrasound Systems Revolutionizing Women's Health Diagnosis

GE HealthCare announced the launch of the Voluson Signature 20 and 18 ultrasound systems, which comprehensively integrate artificial intelligence (AI), adv...

April 18, 2024 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close